# Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease

> **NCT01950507** · PHASE1 · TERMINATED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 15 (actual)

## Conditions studied

- Stem Cell Transplantation
- Graft vs Host Disease

## Interventions

- **DRUG:** Budesonide
- **DRUG:** Fluconazole
- **DRUG:** Voriconazole
- **DRUG:** Micafungin

## Key facts

- **NCT ID:** NCT01950507
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-02-20
- **Primary completion:** 2018-05-10
- **Final completion:** 2020-02-26
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Slow/Insufficient accrual
- **Last updated:** 2021-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01950507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01950507, "Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01950507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*